PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).-Reference-Cited by-同舟云学术

PET/CT with 89Zr-trastuzumab and 18F-FDG to individualize treatment with trastuzumab emtansine (T-DM1) in metastatic HER2-positive breast cancer (mBC).

Published:2014-05-20 Issue:15_suppl Volume:32 Page:11001-11001
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Gebhart Geraldine¹,Lamberts Laetitia E.²,Garcia Camilo¹,Ameye Lieveke³,Stroobants Sigrid⁴,Huizing Manon⁴,Aftimos Philippe G.¹,Tol Jolien⁵,Oyen Wim J.G.⁶,Wimana Zena¹,Dongen G.A.M.S. van⁷,Hoekstra Otto S.⁸,Schroder Carolien P.²,Gaye Julie¹,Menke Catharina Wilhelmina⁹,Guiot Thomas¹,Brouwers Adrienne H.¹⁰,Awada Ahmad¹,de Vries Elisabeth G. E.²,Flamen Patrick¹

Affiliation:

1. Institut Jules Bordet – Université Libre de Bruxelles, Brussels, Belgium

2. Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands

3. Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

4. Antwerp University Hospital, Antwerp, Belgium

5. Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

6. Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands

7. Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands

8. VU University Medical Center, Amsterdam, Netherlands

9. Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

10. Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.11001

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immuno-PET: Design options and clinical proof-of-concept;Frontiers in Medicine;2022-10-14

2. Molecular imaging of biomarkers in breast cancer;Scaffold Press Books;2022-03-31

3. The role of PET in imaging of the tumour microenvironment and response to immunotherapy;Clinical Radiology;2021-10

4. Imaging Considerations and Interprofessional Opportunities in the Care of Breast Cancer Patients in the Neoadjuvant Setting;Seminars in Oncology Nursing;2017-11

5. Imaging Diagnostic and Therapeutic Targets: Human Epidermal Growth Factor Receptor 2;Journal of Nuclear Medicine;2016-02